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A bs tr ac t
Background
Global efforts to eliminate lymphatic filariasis are based on the annual mass ad-
ministration of antifilarial drugs to reduce the microfilaria reservoir available to 
the mosquito vector. Insecticide-treated bed nets are being widely used in areas in 
which filariasis and malaria are coendemic.
Methods
We studied five villages in which five annual mass administrations of antifilarial 
drugs, which were completed in 1998, reduced the transmission of Wuchereria ban-
crofti, one of the nematodes that cause lymphatic filariasis. A total of 21,899 anoph-
eles mosquitoes were collected for 26 months before and 11 to 36 months after bed 
nets treated with long-lasting insecticide were distributed in 2009. We evaluated the 
status of filarial infection and the presence of W. bancrofti DNA in anopheline mos-
quitoes before and after the introduction of insecticide-treated bed nets. We then 
used a model of population dynamics to estimate the probabilities of transmission 
cessation.
Results
Village-specific rates of bites from anopheline mosquitoes ranged from 6.4 to 61.3 
bites per person per day before the bed-net distribution and from 1.1 to 9.4 bites for 
11 months after distribution (P<0.001). During the same period, the rate of detec-
tion of W. bancrofti in anopheline mosquitoes decreased from 1.8% to 0.4% 
(P = 0.005), and the rate of detection of filarial DNA decreased from 19.4% to 14.9% 
(P = 0.13). The annual transmission potential was 5 to 325 infective larvae inoculated 
per person per year before the bed-net distribution and 0 after the distribution. 
Among all five villages with a prevalence of microfilariae of 2 to 38%, the probabil-
ity of transmission cessation increased from less than 1.0% before the bed-net dis-
tribution to a range of 4.9 to 95% in the 11 months after distribution.
Conclusions
Vector control with insecticide-treated bed nets is a valuable tool for W. bancrofti 
elimination in areas in which anopheline mosquitoes transmit the parasite. (Funded 
by the U.S. Public Health Service and the National Institutes of Health.)
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Lymphatic filariasis is a parasitic-worm infection caused by Wuchereria ban-crofti, Brugia malayi, and B. timori that affects 
approximately 120 million people in Africa, Asia, 
the Pacific, and the Americas.1 Adult filarial 
worms live in the lymphatic system, causing lymph-
edema of the limbs, elephantiasis, and hydrocele. 
Fecund adult female worms release micro filariae, 
which ultimately enter the bloodstream, where 
they are ingested by anthropophilic mosquitoes 
of various genera. Microfilariae develop through 
several stages in mosquito vectors until they be-
come infective larvae (L3), which continue trans-
mission by establishing infection in humans 
through the bite site created during blood feed-
ing. Safe, single-dose, inexpensive drug regimens 
have been developed that significantly reduce 
blood loads of microfilariae in humans for more 
than a year. For this reason, lymphatic filariasis 
has been targeted for global elimination by the 
year 2020 on the basis of annual mass adminis-
tration of single-dose albendazole combined with 
either ivermectin or diethylcarbamazine for 5 or 
more years, the estimated reproductive life span 
of adult worms, which is anticipated to break the 
transmission of lymphatic filariasis from hu-
mans to mosquitoes.2,3
Although this effort has had successes, in-
cluding the distribution of drugs to 570 million 
people in 48 countries,4 it is faced with several 
challenges.5 Annual treatment of at least 80% of 
eligible persons is key to elimination, but this level 
of population coverage has proved to be difficult to 
achieve in some areas because of health-system 
constraints6 and human migration.7 Financial and 
political limitations constrain the sustainability 
of control programs for lymphatic filariasis,8 and 
there is the possibility of drug resistance develop-
ing in the parasite population.9 Finally, elimination 
thresholds are site-specific and unknown in most 
areas.10-12 Therefore, program managers in coun-
tries in which lymphatic filariasis is endemic may 
lack the evidence necessary to make informed deci-
sions regarding whether to conclude, continue, or 
reinstitute mass drug-administration campaigns.
Heterogeneities in elimination thresholds for 
lymphatic filariasis are due largely to differences 
in vector–parasite relationships. In anopheline 
mosquitoes, the proportion of microfilariae that 
develop to become infective larvae decreases as 
the number that are ingested decreases, making 
this vector less efficient as the microfilaria res-
ervoir diminishes, whereas the converse occurs 
in lymphatic filariasis transmitted by culicine 
mosquitoes.13 In both systems, a decrease in the 
rate of mosquito bites will increase the worm 
breakpoint (i.e., the threshold below which the 
prevalence of microfilariae spontaneously moves 
to zero).10 Therefore, the elimination of lymphatic 
filariasis becomes more attainable if vector con-
trol accompanies mass drug-administration cam-
paigns. Elimination end points may also be af-
fected by differences in local endemicity, infection 
aggregation, and the magnitude of acquired im-
munity.10 For example, the worm breakpoint has 
been estimated to differ among neighboring vil-
lages in Papua New Guinea, where Anopheles punctu-
latus is the primary vector.11 These difficulties 
suggest that a uniform global strategy for perma-
nent cessation of transmission of lymphatic fila-
riasis may not be resilient and that a lack of vector 
control may hinder progress toward this goal.14
The possibility of including vector control as 
part of programs to eliminate lymphatic filariasis 
has received increased attention.15,16 In sub-Saha-
ran Africa and Papua New Guinea, where anoph-
eles species transmit both W. bancrofti and malaria, 
there is the opportunity to integrate the elimina-
tion of lymphatic filariasis with national malaria-
control programs in which vector interventions 
are an essential component.17 Observations made 
during malaria-eradication efforts in the Solomon 
Islands from 1974 through 1977 support the effi-
cacy of vector control, since indoor residual spray-
ing with insecticides decreased the prevalence of 
microfilariae from 22% to 0% without the use of 
antifilarial drugs.18 Currently, the most widely 
implemented vector intervention used by malaria-
control programs is universal coverage with insec-
ticide-treated bed nets. However, only one study in 
Kenya has examined the effect of conventional 
permethrin-impregnated nets on W. bancrofti trans-
mission by anophelines,19 and there are no data 
that quantify how the use of bed nets treated 
with long-lasting insecticide will complement the 
mass administration of anti filarial drugs in re-
ducing transmission of lymphatic filariasis and 
the probability of cessation of transmission.
We measured the transmission of lymphatic 
filariasis in five villages in the East Sepik Prov-
ince of Papua New Guinea before and after a 
nationwide bed-net distribution effort in 2009. 
Communities in this area had received the last 
of five annual treatments with antifilarial drugs 
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more than 10 years earlier (1998) with no subse-
quent interventions until 2009. Since entomologic 
and human-infection data from this earlier time 
were available,20 we were able to compare mass 
drug administration alone and the distribution of 
insecticide-treated bed nets alone with respect to 
the effect on the rate of transmission of lymphatic 
filariasis in the same region.
Me thods
Study Area
Lymphatic filariasis is highly endemic in Papua 
New Guinea, where it is estimated that 4.4 million 
of the country’s 6.3 million residents live in areas 
that qualify for disease elimination.21 We selected 
five villages in the Ambunti-Dreikikir District of 
East Sepik Province for entomologic surveys and 
quantification of the prevalence of microfilariae 
(Fig. 1). Transmission of lymphatic filariasis in 
these villages has been well characterized.20,22-24
We present our findings in the context of his-
torical endemicity levels on the basis of annual 
transmission potentials (the number of infective 
larvae that were inoculated per person per year), 
which were measured before a trial of mass ad-
ministration of antifilarial drugs conducted from 
1993 through 1998.22
Study Participants
Mosquito collectors and village residents who par-
ticipated in surveys of the prevalence of microfi-
lariae and bed nets provided written informed 
consent after protocols were approved by the in-
stitutional review boards at University Hospitals 
Case Medical Center in Cleveland, the Institute of 
Medical Research, and the Medical Research Ad-
visory Committee in Papua New Guinea.
Prevalence of Microfilariae
We measured the prevalence of microfilariae in 
2008, before the distribution of insecticide-treat-
ed bed nets, by counting the number of microfi-
lariae in a 1-ml sample of nocturnally collected 
venous blood after passing it through a 5-μm poly-
carbonate filter.
Mosquito Collection and Analysis
Mosquitoes were collected monthly after landing 
on human adult collectors from July 2007 through 
July 2010. The collectors sat outdoors within sev-
eral meters of the household entrance from 6 p.m. 
to 6 a.m. with their lower legs and feet exposed. 
Collectors worked in teams, with one member 
collecting from 6 p.m. to midnight and the other 
from midnight to 6 a.m. Mosquitoes landing in 
search of a blood meal were captured with an 
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Figure 1. Location of Study Villages in East Sepik Province, Papua New Guinea.
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aspirator and stored according to the hour they 
were collected. Each village was divided into four 
hamlets, with monthly collections in each ham-
let. The total effort each month varied from 40 to 
48 collection nights. Mosquitoes were morpho-
logically identified as A. punctulatus, A. koliensis, or 
A. farauti sensu lato, according to criteria established 
previously,25 and were stored according to species, 
location, and hour collected. Half the mosquitoes 
were stored in 70% ethanol for later dissection 
and the other half on silica gel for DNA diagnostic 
evaluation, as described below. A total of 10,578 
mosquitoes were stained individually with Mayer’s 
hemalum,26 separated into body sections on a glass 
slide, and dissected with forceps and needles un-
der a microscope. Dissected specimens were ex-
amined for W. bancrofti in the infective larval 
stage and other developing larval stages (L1 and 
L2) with the use of standard criteria.27
Genomic DNA was extracted from unfed dried 
mosquitoes singly or in pools of two (Qiagen). 
Identification of the species of 2867 mosquitoes 
was confirmed with the use of polymerase-chain-
reaction (PCR) amplification of the internal tran-
scribed spacer 2 region of mosquito ribosomal 
DNA and either digested with MSP1 enzyme28 or 
used in a ligase detection reaction–fluorescent 
microsphere assay.29 A total of 1009 samples were 
also screened for W. bancrofti DNA by PCR ampli-
fication of the long DNA repeat region to be used 
as a xenomonitoring tool.30
At the close of the study, one village with a 
moderate transmission level (Nanaha) and one 
with a high transmission level (Yauatong) were se-
lected for long-term assessment of rates of mos-
quito biting. Mosquito collections were conducted 
quarterly in the second and third year after the 
bed-net distribution.
Insecticide-Treated Bed Nets
PermaNet 2.0, an insecticide-treated bed net im-
pregnated with 55 mg of deltamethrin per square 
meter (Vestergaard Frandsen), was distributed to 
study communities by the East Sepik Province 
Division of Health in August 2009. At that time, 
the national target for bed-net coverage was 80% 
of household ownership and 80% use for chil-
dren under the age of 5 years and for pregnant 
women. Surveys regarding bed-net use were con-
ducted in November 2008 and again in Septem-
ber through December 2009 by asking adults 
(≥18 years of age) and parents or guardians of 
children if they had slept under a bed net the 
previous night.
Statistical Analysis
We estimated the daily mosquito-biting rates on 
the basis of the mean number of host-seeking 
anopheline mosquitoes that were collected in a 
12-hour period. We calculated annual transmission 
potentials by multiplying the mean daily biting 
rate in the community by 365, which was then 
multiplied by the proportion of bites that were 
infective and by the mean number of L3 larvae per 
infective bite. We used the Mann–Whitney U test 
to compare biting rates before and after bed-net 
distribution and Fisher’s exact test to compare 
rates of mosquito infection and infectivity before 
and after bed-net distribution. All statistical analy-
ses were performed with the use of PASW Statis-
tics, version 17.0.3 (IBM).
We used a numerical-modeling and Bayesian 
analysis method that was based on the mosqui-
to-biting rate and the prevalence of microfilari-
ae, stratified according to the age of residents in 
the 2008 survey, to estimate the likelihood of 
transmission cessation before and after bed-net 
distribution.10,11 (Details are provided in the Sup-
plementary Appendix, available with the full text 
of this article at NEJM.org.)
R esult s
Prevalence of Human Infection
Descriptive characteristics of the study popula-
tion20 are summarized in Table 1. In 2008, the 
prevalence of microfilariae in the three study vil-
lages in the high-transmission zone ranged from 
23.7% to 38.6%. These values were significantly 
higher than in 1998, when the values ranged 
from 3.7 to 10.8% (P<0.001 by Fisher’s exact test), 
1 year after the fourth annual mass administra-
tion of antifilarial drugs and immediately before 
the fifth and final mass treatment. In contrast, 
the prevalence of microfilariae in the two villag-
es in the moderate-transmission zone, Nanaha 
and Ngahmbule, remained low and did not change 
significantly during the 10-year period, with prev-
alences of 3.4% or less in both villages in 2008 
(P = 0.78 and P = 0.39, respectively, for comparisons 
with 1998 values). Notably, the prevalence of mi-
crofilariae in 2008 did not increase in any of the 
villages to the level in 1994, before mass drug 
administration (Table 1).
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Use of Insecticide-Treated Bed Nets
Immediately before bed-net distribution, 3.8% 
and 12.4% of households of the two study vil-
lages surveyed used bed nets of any type. Four to 
5 months after distribution, self-reported house-
hold use of bed nets in the five study villages 
ranged from 75.0 to 90.6% (Table 1).
Mosquito Vectors
A total of 20,345 anopheline mosquitoes were 
collected in the 26 months before bed-net distri-
bution and 1554 in the 11 months after distribu-
tion. The subgroups of mosquitoes in which the 
species was confirmed included 78% of A. punctu-
latus and 21% of A. koliensis; the remaining 1% was 
a mix of A. hinesorum, A. farauti 4, and A. farauti sensu 
stricto. Among A. koliensis mosquitoes, 94% were 
caught in Nanaha and Ngahmbule; molecular 
confirmation of the morphologic identification of 
A. punctulatus resulted in 95% concordance. Only 
mosquitoes that were identified as A. punctulatus 
on morphologic analysis harbored W. bancrofti in-
fective larvae. Subsequent data are therefore 
based on morphologically identified A. punctulatus.
The proportion of A. punctulatus mosquitoes 
that were infected with any stage of larvae de-
creased from 1.8% to 0.4% after bed-net distri-
bution (P = 0.005 by Fisher’s exact test) (Fig. 2). 
None of the mosquitoes that were collected in 
Peneng, Nanaha, or Ngahmbule after bed-net dis-
tribution contained larvae of any stage. Notably, 
no mosquitoes harboring infective larvae were 
identified in any of the villages after bed-net 
distribution (P = 0.07 by Fisher’s exact test). There-
fore, although annual transmission potentials 
were similar during each of the 2 years preced-
ing bed-net distribution, that number dropped 
to zero for the year after bed-net distribution 
(Fig. 3). The proportion of anopheline mosquitoes 
that tested positive for W. bancrofti DNA, an indi-
cator of the reservoir of microfilariae, was 19.4% 
(761 mosquitoes) before bed-net distribution and 
14.9% (248 mosquitoes) after bed-net distribu-
tion (P = 0.13 by Fisher’s exact test).
Mosquito-Biting Rates
The daily biting rates for anopheline mosquitoes 
decreased significantly after bed-net distribution, 
with a mean (±SE) of 61.3±4.9 bites per person 
per day before bed-net distribution versus 9.4±1.9 
after bed-net distribution in Yauatong, 22.6±2.5 
versus 7.3±2.0 in Albulum, 6.4±0.8 versus 1.5±0.4 
in Peneng, 21.5±1.3 versus 1.1±0.2 in Nanaha, 
and 8.9±0.8 versus 1.5±0.3 in Ngahmbule (P<0.001 
for all comparisons by the Mann–Whitney U test). 
The rates remained consistently low for an addi-
tional 2 years in Yauatong and Nanaha (Fig. 4).
The probability of the transmission cessation 
was less than 1.0% in all five villages before 
bed-net distribution. After bed-net distribution, 
the probabilities increased to 4.9%, 7.7%, 90.5%, 
95.8%, and 61.5% in Yauatong, Albulum, Peneng, 
Nanaha, and Ngahmbule, respectively. Further 
reductions in biting rates by years 2 and 3 after 
bed-net distribution increased the probabilities 
to 36.8% and more than 99% in Yauatong and 
Nanaha, respectively. These high probabilities pro-
vide support for the empirical finding that an-
nual transmission potentials were reduced to 
zero after bed-net distribution (Fig. 2).
Table 1. Status of Lymphatic Filariasis and Use of Insecticide-Treated Bed Nets in the Study Villages.*
Level of 
Transmission
Village 
Name Microfilariae Prevalence
Population
of Village
Bed-Net Use before 
Distribution in 2009
Bed Nets
Distributed
Bed-Net Use after 
Distribution
1994 1998 2008
% no. % no. %
High Yauatong 79.5 10.8 38.6 408 12.4 190 84.3
High Albulum 78.3 7.4 38.4 526 NA 234 81.7
High Peneng 61.5 3.7 23.7 233 3.8 142 75.0
Moderate Nanaha 48.3 2.4 2.0 507 NA 222 84.1
Moderate Ngahmbule 36.2 1.7 3.4 256 NA 109 90.6
* Transmission levels are based on annual transmission potentials determined in 1993 and 1994. Five annual mass antifilarial treatments 
consisting of diethylcarbamazine alone or diethylcarbamazine plus ivermectin were administered from 1994 through 1998. (This regimen 
differed from the standard treatment in the global program to eliminate lymphatic filariasis.) Insecticide-treated bed nets were distributed in 
August 2009, with a target coverage of at least 80% of households per village. NA denotes not available.
The New England Journal of Medicine 
Downloaded from nejm.org at UQ Library on March 30, 2017. For personal use only. No other uses without permission. 
 Copyright © 2013 Massachusetts Medical Society. All rights reserved. 
T h e  n e w  e ngl a nd  j o u r na l  o f  m e dic i n e
n engl j med 369;8 nejm.org august 22, 2013750
Discussion
Residents of villages in our study participated in 
a 5-year program of mass administration of anti-
filarial drugs, with 77 to 86% of eligible residents 
receiving such drugs annually from 1994 through 
1998.20 The prospect of the elimination of lym-
phatic filariasis was promising at the end of the 
campaign and seemed even more likely after a 
2003 survey showed very few mosquitoes contain-
ing developing larvae, no mosquitoes containing 
infective larvae, and no children under the age of 
10 years who tested positive for filarial antigen.24 
However, it is clear from observations in 2008 
and 2009 that transmission was still occurring, 
since annual transmission potentials among the 
study villages ranged from 5 to 325 infective lar-
vae that were inoculated per person per year, and 
the prevalence of microfilariae had significantly 
rebounded in three villages. Human migration 
may have contributed to continuing transmission 
and increased prevalence of microfilariae after 
the cessation of mass treatment.31 The fact that 
worm breakpoints that were necessary for the ces-
sation of transmission were not attained is prob-
ably of greater importance. In 1997, after four 
annual mass drug administrations, the prevalence 
of microfilariae in moderate- and high-transmis-
sion zones was 1% and 5%, respectively.20 How-
ever, worm breakpoints for anopheline systems 
are estimated to be 0.75%.11
The introduction of insecticide-treated bed nets 
profoundly affected the vector population and 
therefore the transmission of lymphatic filariasis. 
A similar proportion of mosquitoes tested posi-
tive for W. bancrofti DNA before and after bed-net 
distribution. However, significantly fewer mos-
quitoes contained developing worms after bed-
net distribution. These findings indicate that 
mosquitoes were imbibing microfilaremic blood, 
but larval development was interrupted. The use 
of bed nets may reduce the transmission of vec-
torborne diseases by shortening the life span of 
mosquitoes,32 and W. bancrofti microfilariae re-
quire at least 13 days to develop into infective 
larvae in A. punctulatus.33 Therefore, a slight re-
duction in average life span could have a major 
effect on the number of infective larvae. In addi-
tion, after the introduction of bed nets, most 
mosquitoes that fed successfully probably were 
feeding before residents went to bed. We saw 
that a greater proportion of the mosquito popu-
lation was biting at earlier hours after bed nets 
were introduced. Because of the nocturnal peri-
odicity of microfilaremia in Papua New Guinea, 
earlier biters will ingest fewer microfilariae than 
those biting during the time of peak blood den-
sity of microfilariae (around 1:30 a.m.) (Fig. S1 
in the Supplementary Appendix).
Previous studies have shown how vector con-
trol alone can be used to reduce the prevalence 
of microfilariae34 and to accelerate this decrease 
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when combined with mass administration of an-
tifilarial drugs.35,36 However, our study quanti-
fies the effect of the most widely implemented 
vector-control measure, the use of insecticide-
treated bed nets. Although vector control is not 
currently a part of the global strategy to eliminate 
lymphatic filariasis, universal bed-net distribution 
is now used widely for malaria control-and-elim-
ination efforts in Papua New Guinea and sub-
Saharan Africa. Thus, our study highlights the 
importance of integrating vectorborne disease 
interventions. However, in order for the use of 
bed nets to be a sustainable strategy to eliminate 
lymphatic filariasis, biting rates must remain be-
low the threshold until lymphatic-dwelling adult 
worms in the population die. The likelihood of 
transmission cessation that we observed is a 
snapshot of a temporally dynamic transmission 
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with cessation probabilities of 50%, 75% and 95%. The bars at the bottom of the panel indicate the frequency distribution of the model-
estimated biting thresholds for Peneng. Panels B through F show changes in the mosquito-biting rate and probabilities of cessation in 
the five study villages before the distribution of insecticide-treated bed nets and 1 or more years after bed-net distribution. (Mosquito-
biting rates were available for Yauatong and Nanaha for years 2 and 3 after the distribution.) Shown are estimates (open circles) of the 
most likely 500 biting thresholds calculated by goodness of fit of the model with 2008 data regarding the prevalence of microfilariae, 
stratified according to the age of residents in the five villages in the study. The shaded bands between dashed lines denote the range 
and biting threshold values associated with 5%, 50%, and 95% probabilities of transmission cessation. The diamonds indicate mea-
sured biting rates, and the I bars 95% confidence intervals.
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system. A small increase in biting rate with no 
change in human prevalence of microfilariae 
could quickly lead to a reestablishment of stable 
transmission.
Program managers wanting to determine trans-
mission end points during elimination campaigns 
are met with the challenge of detecting human 
infection at progressively lower levels.37 In our 
study, we used data on the prevalence of micro-
filariae before the intervention and a model of 
the transmission of lymphatic filariasis to quan-
tify the probability of transmission cessation on 
the basis of mosquito-biting rates alone. Annual 
transmission potentials dropped to zero after bed-
net distribution in all villages on the basis of an 
absence of infective larvae in blood-seeking mos-
quitoes, though detection of infective mosquitoes 
was constrained by very low vector densities. The 
probability of transmission cessation was more 
than 50% in the two moderate-transmission vil-
lages, where the prevalence of microfilariae was 
3.4% or less before bed-net distribution. A simi-
lar likelihood of transmission cessation was 
calculated for Peneng, where the prevalence of 
microfilariae in 2008 was 23.7%, but the mos-
quito-biting rate was similar to rates in the moder-
ate-transmission villages after bed-net distribution.
If the use of bed nets remains high and vector 
populations continue to be susceptible, the use 
of bed nets may eliminate lymphatic filariasis in 
areas where the reservoir of microfilariae has 
first been reduced by mass drug administration, 
as in the populations included in this study, or 
where preintervention endemicity is already low, 
such as in the Solomon Islands.18 In high-trans-
mission areas, the use of bed nets could work 
synergistically with mass drug administration by 
increasing the worm breakpoint to a more easily 
attainable level. Given the challenges of reaching 
80% compliance with mass drug administration 
for at least 5 years,38,39 efforts to eliminate lym-
phatic filariasis would greatly benefit from inte-
grated vector management.40
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